Sotera Health (SHC) Projected to Post Earnings on Thursday

Sotera Health (NASDAQ:SHC) will likely be issuing its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.24 per share and revenue of $300.68 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 9:00 AM ET.

Sotera Health Price Performance

Shares of SHC opened at $17.45 on Thursday. The company has a debt-to-equity ratio of 4.04, a current ratio of 2.38 and a quick ratio of 2.18. Sotera Health has a 1-year low of $9.53 and a 1-year high of $19.85. The stock has a market cap of $4.96 billion, a PE ratio of 91.85 and a beta of 1.82. The firm has a fifty day moving average price of $17.95 and a 200 day moving average price of $16.64.

Insider Activity

In related news, Director Pincus & Co. Warburg sold 9,720,000 shares of the stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the completion of the transaction, the director directly owned 34,102,952 shares of the company’s stock, valued at $556,901,206.16. This represents a 22.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of Sotera Health stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total value of $105,818,400.00. Following the completion of the sale, the director directly owned 22,735,301 shares in the company, valued at $371,267,465.33. This represents a 22.18% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 17,384,104 shares of company stock valued at $284,024,511 over the last quarter. Corporate insiders own 47.55% of the company’s stock.

Hedge Funds Weigh In On Sotera Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Mercer Global Advisors Inc. ADV increased its holdings in shares of Sotera Health by 325.1% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 77,150 shares of the company’s stock valued at $1,361,000 after purchasing an additional 59,001 shares in the last quarter. First Citizens Bank & Trust Co. grew its position in Sotera Health by 1.5% during the fourth quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company’s stock worth $1,169,000 after buying an additional 970 shares during the period. State of Tennessee Department of Treasury purchased a new position in Sotera Health in the fourth quarter valued at about $943,000. Empowered Funds LLC lifted its position in shares of Sotera Health by 7.1% during the 4th quarter. Empowered Funds LLC now owns 22,850 shares of the company’s stock valued at $403,000 after acquiring an additional 1,510 shares during the period. Finally, Utah Retirement Systems purchased a new stake in shares of Sotera Health during the 4th quarter worth approximately $191,000. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SHC has been the subject of a number of research analyst reports. Wells Fargo & Company cut Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Royal Bank Of Canada initiated coverage on Sotera Health in a report on Thursday, January 8th. They issued an “outperform” rating and a $24.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. BMO Capital Markets initiated coverage on shares of Sotera Health in a research report on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price target for the company. Finally, Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $17.00 to $24.00 in a research report on Friday, January 9th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.00.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.